Kazakh esophageal squamous cell carcinoma (ESCC) exhibited unusually high levels of HLA-DQ, HLA-DR and HLA-DP, whereas later clinical stages had reduced expression of the corresponding genes, indicating that decreased MHC-II molecules facilitated immune escape and tumor progression [84]. The gene discussed is HLA-DPB1; the disease is esophageal squamous cell carcinoma.